Premium
Production and Glycosylation of Recombinant β‐Interferon in Suspension and Cytopore Microcarrier Cultures of CHO Cells
Author(s) -
Spearman Maureen,
Rodriguez Jose,
Huzel Norm,
Butler Michael
Publication year - 2008
Publication title -
biotechnology progress
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.572
H-Index - 129
eISSN - 1520-6033
pISSN - 8756-7938
DOI - 10.1021/bp0498084
Subject(s) - microcarrier , recombinant dna , bioprocess , cell culture , glycosylation , chinese hamster ovary cell , chemistry , suspension culture , biology , microbiology and biotechnology , biochemistry , cell , gene , paleontology , genetics
Microcarriers are suitable for high‐density cultures of cells requiring surface attachment and also offer the advantage of easy media removal for product recovery. We have used the macroporous microcarriers Cytopore 1 and 2 for the growth of CHO cells producing recombinant human β‐interferon (β‐IFN) in stirred batch cultures. Although these cells may grow in suspension, in the presence of Cytopore microcarriers they become entrapped in the inner bead matrix where they can be maintained at high densities. Cell growth rates were reduced in microcarrier cultures compared to suspension cultures. However, the β‐IFN yield was up to 3‐fold greater as a result of an almost 5‐fold higher specific productivity. Maximum productivity was found in cultures containing 1.0 mg/mL of Cytopore 1 or 0.5 mg/mL of Cytopore 2 with a cell/bead ratio of 1029 and 822, respectively. β‐IFN molecules aggregated in the later stages of all cultures, causing a decrease in response by ELISA. However, the degree of aggregation was significantly less in the microcarrier cultures. The N‐linked glycans from β‐IFN were isolated and analyzed by normal phase HPLC. There was no apparent difference in the profile of glycans obtained from each of the suspension and Cytopore culture systems. This suggests that Cytopore microcarriers may be useful in bioprocess development for enhanced recombinant glycoprotein production without affecting the glycosylation profile of the protein.